Bloomberg Businessweek

• Paramount Ups Battle for Warner Bros. With Hostile Bid

  Watch Bloomberg Businessweek Daily LIVE every day on YouTube: http://bit.ly/3vTiACF. The fight over the future of Hollywood just got nastier. Paramount Skydance Corp. launched a hostile takeover bid for Warner Bros. Discovery Inc. at $30 a share in cash on Monday, just days after the company agreed to a deal with Netflix Inc. The offer values Warner Bros. at $108.4 billion, including debt. The bid compares with Netflix’s offer of $27.75 in cash and stock, for an enterprise value of about $82.7 billion including debt. Paramount’s offer is for all of Warner Bros., while Netflix is interested only in the Hollywood studios, HBO and the streaming business. Warner Bros. investors “deserve an opportunity to consider our superior all-cash offer for their shares in the entire company,” Paramount Chief Executive Officer David Ellison said in a statement. The battle between Netflix and Paramount stands to reshape the entertainment industry regardless of who wins. With Warner Bros. films and TV shows, Netflix would wield tremendous new power over the content offered to online audiences. Paramount aims to marry two legacy Hollywood studios to counter the influence of Netflix, Walt Disney Co. and Amazon.com Inc. Both bids raise significant antitrust concerns, underscored by multibillion-dollar breakup fees the parties have offered, and both companies have been laying the groundwork to win over the White House. Today's show features: Bloomberg News Media and Entertainment Editor Felix Gillette and Bloomberg News Intelligence Senior Media Analyst Geetha Ranganathan on Paramount’s $108 billion hostile takeover bid for Warner Bros. Discovery Kevin Gordon, Head of Macro Research and Strategy for the Schwab Center for Financial Research, on inflation, labor and AI investing trends Bloomberg News Chief Wall Street Correspondent Sridhar Natarajan and US Insurance Reporter Alex Rajbhandari on the ripple effects of JPMorgan hiring Todd Combs away from Berkshire Hathaway Gracelin Baskaran, Director of Critical Minerals Security Program at Center for Strategic and International Studies, on the US and Democratic Republic of Congo signing a partnership to create a strategic reserve of critical mineral assets and current state of play in the sector See omnystudio.com/listener for privacy information.

  --------  

  34:25

  --------

  34:25
• New Hope for People Battling With Depression

  Compass Pathways is a mental health care company developing new treatments for people who haven’t responded to existing medications and continue to struggle with their mental health. The company was the first to report successful Phase 3 clinical trial results for a psychedelic treatment, known as COMP360 psilocybin, for treatment-resistant depression (TRD) and is positioned to potentially be the first to receive regulatory approval and bring a psychedelic-based medicine to market.Kabir Nath, the CEO of Compass Pathways, details his company's path building a scalable, safe, and accessible psychedelic care system and model. Kabir speaks with Carol Massar and Alexis Christoforous on Bloomberg Businessweek Daily.See omnystudio.com/listener for privacy information.

  --------  

  11:42

  --------

  11:42
• Bloomberg Businessweek Weekend - December 5th, 2025

  Featuring some of our favorite conversations of the week from our daily radio show "Bloomberg Businessweek Daily."Hosted by Carol Massar and Tim StenovecHear the show live at 2PM ET on WBBR 1130 AM New York, Bloomberg 92.9 FM Boston, WDCH 99.1 FM in Washington D.C. Metro, Sirius/XM channel 121, on the Bloomberg Business App, Radio.com, the iHeartRadio app and at Bloomberg.com/audio.You can also watch Bloomberg Businessweek on YouTube - just search for Bloomberg Global News.Like us at Bloomberg Radio on Facebook and follow us on Twitter @carolmassar @timsteno and @BWSee omnystudio.com/listener for privacy information.

  --------  

  1:14:08

  --------

  1:14:08
• Netflix to Buy Warner Bros. in Historic $72 Billion Deal

  Watch Bloomberg Businessweek Daily every day on YouTube: http://bit.ly/3vTiACF.Netflix Inc. agreed to buy Warner Bros. Discovery Inc., marking a seismic shift in the entertainment business as a Silicon Valley-bred streaming giant tries to swallow one of Hollywood’s oldest and most revered studios.Under terms of the deal announced Friday, Warner Bros. shareholders will receive $27.75 a share in cash and stock in Netflix, valuing the business at $82.7 billion including debt. The total equity value of the deal is $72 billion. Warner Bros. will spin off cable networks such as CNN and TNT into a separate company before concluding the sale of its studio and HBO to Netflix. Media mergers of this scale have a rocky history and this one is expected to bring intense regulatory scrutiny in the US and Europe. Paramount Skydance Corp., which accused Warner Bros. of running an unfair sales process, could also take steps to disrupt the transaction, like by taking an offer directly to shareholders. The company declined to comment.The Netflix deal combines two of the world’s biggest streaming providers with some 450 million subscribers. Warner Bros.’ deep library of programming gives Netflix content to sustain its lead over challengers like Walt Disney Co. and Paramount.Today's show features: Bloomberg News Media and Entertainment Editor Felix Gillette on Netflix agreeing to buy Warner Bros. Discovery Inc. in a deal valuing the business at $82.7 billion including debt Karin Kimbrough, Chief Economist at LinkedIn, on the health of the US labor market and economy Rebecca Homkes, Faculty at the London Business School and at Duke Corporate Executive Education, on how executives should be evaluating the health of consumers, market concentration risk and AI bubble concerns Bloomberg Tech Co-Host Ed Ludlow on Elon Musk’s SpaceX reportedly telling investors and financial institution representatives that it is aiming for an initial public offering in 2026 Bloomberg News Senior Editor, Equities Americas Eric Weiner recaps the week in markets and looks ahead to the Federal Reserve’s upcoming rate decision See omnystudio.com/listener for privacy information.

  --------  

  37:57

  --------

  37:57
• NIH Backs Leading Cardiologist's Work on Women's Heart Health

  Dr. Nupoor Narula, MD, MSc is the Bruce Lerman Clinical Scholar, cardiologist, and Director of the Cardiology Vascular Laboratory and Women’s Heart Program at Weill Cornell Medicine. An NIH-funded physician-investigator, her clinical and research interests include genetic aortic diseases and aortic aneurysms and dissections, with a special emphasis on these conditions in women and pregnancy. Dr. Narula recently received funding from the National Institutes of Health for her research on aortic aneurysms, and the NIH continues to fund related research in the area of women's heart health, which may signal a greater appetite to invest in, and prioritize an increasingly important clinical need. Dr. Narula details her work on cardiac risks to women, particularly during pregnancy, with Carol Massar and Alexis Christoforous on Bloomberg Businessweek Daily.See omnystudio.com/listener for privacy information.

  --------  

  8:37

  --------

  8:37

More Business podcasts

Trending Business podcasts

About Bloomberg Businessweek

Bloomberg Businessweek: Podcasts in Family